– IMscin001 study showed non-inferior levels of cancer immunotherapy Tecentriq in the blood, when injected subcutaneously, compared to intravenous infusion, in people with advanced non-small cell lung cancer – – Administered under the skin, the subcutaneous formulation reduces time spent receiving treatment to just minutes, compared with up to an hour for IV infusion – … [Read more…]
All regulatory clearances received for the acquisition of Vifor Pharma AG Settlement of the offer is scheduled for 9 August 2022 Seasoned biopharma executive, Hervé Gisserot, designated to lead the business as General Manager upon settlement of the offer MELBOURNE, Australia & ST. GALLEN, Switzerland–(BUSINESS WIRE)–Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR … [Read more…]
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first subject has been dosed in clinical trial of the Company’s TYK2 JH2 allosteric inhibitor ICP-488 in China. ICP-488 is a potent and selective TYK2 (tyrosine kinase 2) allosteric inhibitor being developed for … [Read more…]
The investment values Kerecis at $620 million REYKJAVIK, Iceland & BILLUND, Denmark & ARLINGTON, Va.–(BUSINESS WIRE)–#kerecis—Kerecis® today announced that it completed its $100 million Series D financing that was led by KIRKBI, the family holding and investment company behind the LEGO Group. Kerecis is the company pioneering the use of sustainably sourced fish skin and … [Read more…]
Partnership provides value-based payment analytics and insights to optimize performance under new Medicare risk arrangement for the Clinically Integrated Network. HONOLULU & LOS ANGELES–(BUSINESS WIRE)–#Medicare–Please replace the second logo of release dated July 28, 2022, with the accompanying corrected logo. The release reads: HAWAII HEALTH NETWORK AND COPE HEALTH SOLUTIONS PARTNER ON POPULATION HEALTH ANALYTICS … [Read more…]
EMERYVILLE, Calif.–(BUSINESS WIRE)–#earnings—Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that effective August 1, 2022, Ligand’s Board of Directors approved the grant of non-qualified stock option awards to purchase an aggregate of 90,073 shares of its common stock, 5,000 restricted stock units (“RSUs”) and 4,000 performance stock units (“PSUs”) (at the target level) to six non-executive … [Read more…]
Company to Distribute Recent FDA-Approved Treatment for Reducing Bad Cholesterol FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare–Headline of release dated July 26, 2022, should read: Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO® The updated release reads: SOLEO HEALTH SELECTED AS LIMITED DRUG DISTRIBUTION PARTNER FOR ADMINISTRATION OF LEQVIO® Company to Distribute Recent FDA-Approved Treatment … [Read more…]
The simple and easy to use Dexcom ONE rt-CGM system is now listed on the NHS England, Wales, Scotland and Northern Ireland drug tariffs The first of Dexcom’s scan-free and finger prick-free† devices available on prescription for people with Type 1 diabetes and Type 2 insulin dependent diabetes LONDON–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM), the global leader … [Read more…]
MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that the company’s management team will be participating in one-on-one meetings at the upcoming BTIG Biotechnology Conference, which is taking place both virtually and at the St. Regis New York Hotel in … [Read more…]
SAN DIEGO–(BUSINESS WIRE)–$ARCT #ClinicalTrial–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global, late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it will release its financial results for the quarter ended June 30, 2022 after the … [Read more…]
